Papenfuss TL - Search Results

1

Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.

Collier MA, Peine KJ, Gautam S, Oghumu S, Varikuti S, Borteh H, Papenfuss TL, Sataoskar AR, Bachelder EM, Ainslie KM. Collier MA, et al. Among authors: papenfuss tl. Int J Pharm. 2016 Feb 29;499(1-2):186-194. doi: 10.1016/j.ijpharm.2016.01.004. Epub 2016 Jan 5. Int J Pharm. 2016. PMID: 26768723 Free PMC article.

2

Efficient delivery of the toll-like receptor agonists polyinosinic:polycytidylic acid and CpG to macrophages by acetalated dextran microparticles.

Peine KJ, Bachelder EM, Vangundy Z, Papenfuss T, Brackman DJ, Gallovic MD, Schully K, Pesce J, Keane-Myers A, Ainslie KM. Peine KJ, et al. Mol Pharm. 2013 Aug 5;10(8):2849-57. doi: 10.1021/mp300643d. Epub 2013 Jun 27. Mol Pharm. 2013. PMID: 23768126

3

A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani.

Gupta G, Peine KJ, Abdelhamid D, Snider H, Shelton AB, Rao L, Kotha SR, Huntsman AC, Varikuti S, Oghumu S, Naman CB, Pan L, Parinandi NL, Papenfuss TL, Kinghorn AD, Bachelder EM, Ainslie KM, Fuchs JR, Satoskar AR. Gupta G, et al. Among authors: papenfuss tl. ACS Infect Dis. 2015 Oct 9;1(10):497-506. doi: 10.1021/acsinfecdis.5b00081. Epub 2015 Sep 21. ACS Infect Dis. 2015. PMID: 27623316 Free PMC article.

4

Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani.

Rosas LE, Snider HM, Barbi J, Satoskar AA, Lugo-Villarino G, Keiser T, Papenfuss T, Durbin JE, Radzioch D, Glimcher LH, Satoskar AR. Rosas LE, et al. J Immunol. 2006 Jul 1;177(1):22-5. doi: 10.4049/jimmunol.177.1.22. J Immunol. 2006. PMID: 16785492

5

Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics.

Papenfuss TL, Himmel L, Kuper CF, Mohanan S, Harleman J, Elmore SA. Papenfuss TL, et al. Toxicol Pathol. 2023 Jun;51(4):205-215. doi: 10.1177/01926233231190382. Epub 2023 Aug 14. Toxicol Pathol. 2023. PMID: 37578155

6

In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene.

Lanigan LG, Hildreth BE 3rd, Dirksen WP, Simmons JK, Martin CK, Werbeck JL, Thudi NK, Papenfuss TL, Boyaka PN, Toribio RE, Ward JM, Weilbaecher KN, Rosol TJ. Lanigan LG, et al. Among authors: papenfuss tl. Am J Pathol. 2021 Feb;191(2):335-352. doi: 10.1016/j.ajpath.2020.10.014. Epub 2020 Nov 9. Am J Pathol. 2021. PMID: 33181139 Free PMC article.

7

MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of Infection.

Varikuti S, Natarajan G, Volpedo G, Singh B, Hamza O, Messick GV, Guerau-de-Arellano M, Papenfuss TL, Oghumu S, Satoskar AR. Varikuti S, et al. Among authors: papenfuss tl. Infect Immun. 2019 Jul 23;87(8):e00307-19. doi: 10.1128/IAI.00307-19. Print 2019 Aug. Infect Immun. 2019. PMID: 31182615 Free PMC article.

8

The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani.

Varikuti S, Volpedo G, Saljoughian N, Hamza OM, Halsey G, Ryan NM, Sedmak BE, Seidler GR, Papenfuss TL, Oghumu S, Satoskar AR. Varikuti S, et al. Among authors: papenfuss tl. J Infect Dis. 2019 Jan 29;219(4):599-608. doi: 10.1093/infdis/jiy552. J Infect Dis. 2019. PMID: 30239895 Free PMC article.

9

CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions.

Amici SA, Young NA, Narvaez-Miranda J, Jablonski KA, Arcos J, Rosas L, Papenfuss TL, Torrelles JB, Jarjour WN, Guerau-de-Arellano M. Amici SA, et al. Among authors: papenfuss tl. Front Immunol. 2018 Jul 10;9:1593. doi: 10.3389/fimmu.2018.01593. eCollection 2018. Front Immunol. 2018. PMID: 30042766 Free PMC article.

10

Transgenic T cell-specific expression of CXCR3 enhances splenic and hepatic T cell accumulation but does not affect the outcome of visceral leishmaniasis.

Varikuti S, Natarajan G, Oghumu S, Sperling RH, Moretti E, Stock J, Papenfuss TL, Satoskar AR. Varikuti S, et al. Among authors: papenfuss tl. Cell Immunol. 2016 Nov;309:61-68. doi: 10.1016/j.cellimm.2016.08.016. Epub 2016 Sep 6. Cell Immunol. 2016. PMID: 27614845 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page